Deepa Bhojwani

16PUBLICATIONS
103CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Nanotoxicology, health and safetyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursNeonatology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Oct 20, 2026
A real-world multi-institution experience of standard versus alternative dosing regimens of inotuzumab ozogamicin for relapsed/refractory paediatric B-cell acute lymphoblastic leukaemia.

|Dec 17, 2024
Clinical Actionability of the NUDT15 *4 (p.R139H) Allele and Its Association With Hispanic Ethnicity.

Maud Maillard, Jenny Q Nguyen, Wenjian Yang

|Dec 03, 2024
CD33-CD123 IF-THEN Gating Reduces Toxicity while Enhancing the Specificity and Memory Phenotype of AML-Targeting CAR-T Cells.

Samy Jambon, Jianping Sun, Shawn Barman

|Sep 11, 2024
Determinants of survival after first relapse of acute lymphoblastic leukemia: a Children's Oncology Group study.

Susan R Rheingold, Deepa Bhojwani, Lingyun Ji

|Aug 16, 2024
Anti-CD7 allogeneic WU-CART-007 in patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma: a phase 1/2 trial.

Armin Ghobadi, Ibrahim Aldoss, Shannon Maude

|Jun 26, 2024
Severe steroid-related neuropsychiatric symptoms during paediatric acute lymphoblastic leukaemia therapy-An observational Ponte di Legno Toxicity Working Group Study.

Stavroula Anastasopoulou, Gemma Swann, Liv Andres-Jensen

Pageof 3

Frequent Collaborators

3 joint publications

Susan R Rheingold

2 joint publications

Mignon L Loh

2 joint publications

Alan Wayne

2 joint publications

Brent L Wood